The office gazette of Paris
The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals. The treatment is expected to be a breakthrough by aiding weight reduction, which in turn improves breathing during sleep.
A 17-year-old student in Kanpur endured months of horrific abuse after being lured to a fake New Year’s party by her coaching teacher, Sahil Siddiqui. […]
BJP criticized the DMK-Congress alliance in Tamil Nadu after reports surfaced that police mistreated the parents of a minor rape survivor while the accused remains […]
A thick layer of smog has engulfed parts of Delhi, with the Air Quality Index (AQI) consistently in the ‘very poor’ category, reaching hazardous levels. […]